albutropin (TV-1106)
/ Teva
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 13, 2013
Safety, tolerability and efficacy of weekly TV-1106 in adults with growth hormone deficiency
(clinicaltrials.gov)
- P2, N=50; Sponsor: Teva; Not yet recruiting; New P2 trial.
New P2 trial • Growth Hormone
1 to 1
Of
1
Go to page
1